IL6 and non-small cell lung carcinoma: For example, LINC01288 can interact directly with and increase the stability of interleukin 6 (IL-6) mRNA, leading to upstream activation of the signal transducer and activator of transcription 3 (STAT3) pathway, promoting NSCLC proliferation, growth, and invasion [63].